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A highly conserved arginine residue is close to the catalytic center of PPM/PP2C-type protein phosphatases. Diﬀerent crystal
structures of PPM/PP2C homologues revealed that the guanidinium side chain of this arginine residue can adopt variable
conformations and may bind ligands, suggesting an important role of this residue during catalysis. In this paper, we randomly
mutated Arginine 13 of tPphA, a PPM/PP2C-type phosphatase from Thermosynechococcus elongatus, and obtained 18 diﬀerent
amino acid variants. The generated variants were tested towards p-nitrophenyl phosphate and various phosphopeptides. Towards
p-nitrophenyl phosphate as substrate, twelve variants showed 3–7 times higher Km values than wild-type tPphA and four
variants (R13D, R13F, R13L, and R13W) completely lost activity. Strikingly, these variants were still able to dephosphorylate
phosphopeptides, although with strongly reduced activity. The speciﬁc inability of some Arg-13 variants to hydrolyze p-
nitrophenyl phosphate highlights the importance of additional substrate interactions apart from the substrate phosphate for
catalysis. The properties of the R13 variants indicate that this residue assists in substrate binding.
1.Introduction
The protein serine/threonine phosphatases constitute two
large families, the phosphoprotein phosphatases (PPP) and
the metal-dependent protein phosphatases (PPM) and one
small family, the aspartate-based phosphatases [1]. The
human PPM member PP2Cα [2] has been the deﬁning
representative of the PPM family, which is therefore also
referred as the PP2C family. PP2C phosphatases are widely
present in eukaryotes and prokaryotes where they regu-
late diverse signaling pathways involved in central cellular
processes, such as cell proliferation, stress responses, or
metabolic activity [3]. Recently, several crystal structures of
bacterial and plant PP2Cs were solved, and they all show
that ﬁve highly conserved aspartate residues constitute a
negative charged pocket that coordinates three Mg2+/Mn2+
(M1, M2, and M3) ions in the catalytic center [4–9]. All
three metal ions were proven by mutational analysis of the
coordinating Asp residues to be essential for the activity of
PP2Cs [2, 10–12]. Recently, we have reported that the third
metal (M3) in the catalytic centre of tPphA (a PP2C member
from Thermosynechococcus elongatus) takes part in catalysis,
presumably by activating a water molecule to act as proton
donor for the leaving group [11]. Recently, further regions in
the periphery of the catalytic core of tPphA were identiﬁed
to play roles in substrate recognition: His-39, a conserved
residue in bacterial PP2C members, and the variable ﬂap-
subdomain facing M3 [13].
According to the PP2C motif nomenclature of Bork et al.
1996 [14], a conserved arginine residue located in the begin-
ning of motif 1 and structurally close to the catalytic center
of PP2C may play an important role in catalysis as deduced
from structural analysis. The guanidinium side chain of
this arginine residue could adopt diﬀerent conformations
in various PP2C structures; the crystal structures of human
PP2Cα [2] and MspP (a PP2C member from Mycobacterium
smegmatis)[ 6] in complex with a phosphate ion revealed
that this arginine residue is hydrogen bonded with one
oxygen atom of the phosphate ion in the catalytic pocket.
Enzymatic assays of a human PP2Cα variant, where the2 Enzyme Research
Table 1: Primers used for PCR ampliﬁcation of tPphA and for site-directed mutagenesis.
T7 5 ;5  -TAATACGACTCACTATAGGG-3 
3 ;5  -GCTAGTTATTGCTCAGCGG-3 
R13X 5 ;5  -CTGACTGTGGTCTGATTNNNAAAAGCAATCAGGATGC-3 
3 ;5  -GCATCCTGATTGCTTTTNNNAATCAGACCACAGTCAG-3 
R13A 5 ;5  -CTGACTGTGGTCTGATTGCTAAAAGCAATCAGGATGC-3 
3 ;5  -GCATCCTGATTGCTTTTAGCAATCAGACCACAGTCAG-3 
R13C 5 ;5  -CTGACTGTGGTCTGATTTGTAAAAGCAATCAGGATGC-3 
3 ;5  -GCATCCTGATTGCTTTTACAAATCAGACCACAGTCAG-3 
R13E 5 ;5  -CTGACTGTGGTCTGATTGAAAAAAGCAATCAGGATGC-3 
3 ;5  -GCATCCTGATTGCTTTTTTCAATCAGACCACAGTCAG-3 
R13V 5 ;5  -CTGACTGTGGTCTGATTGTTAAAAGCAATCAGGATGC-3 
3 ;5  -GCATCCTGATTGCTTTTAACAATCAGACCACAGTCAG-3 
Arg-33 residue was replaced by Ala showed that this arginine
residue is important for binding p-nitrophenyl phosphate
(pNPP), since the variant R33A shows 8-fold higher Km than
wild-type phosphatase [12]. The crystal structures of MspP
incomplexwithsulphateandcacodylatewerealsosolved[6].
In the crystal structure of MspP with sulphate, the conserved
arginine residue (Arg-17 of MspP) is hydrogen bonded with
the sulphate ion, which is dislodged from the catalytic center
of MspP. It was, therefore, suggested that this conformation
of Arg-17 adapt to the incoming phosphoprotein substrate
or the outgoing inorganic phosphate after catalysis, implying
that Arg-17 might assist in releasing inorganic phosphate
after catalysis [6]. In the crystal structure of MspP with
cacodylate, MspP Arg-17 makes a hydrogen bond with a
water molecule, whereas the two oxygen atoms of cacodylate
are coordinated by M1 and M2. A crystal of SaS T P( aP P 2 C
member from Streptococcus agalactiae) with four monomers
(A, B, C, and D) in the asymmetric unit revealed monomer
C in a conformation, which interacted with the ﬂap subdo-
main of the adjacent monomer A [7]. The corresponding
arginine residue (Arg-13 of SaSTP) side chain showed two
diﬀerent conformations in monomer A and C, respectively.
InmonomerA,itsconformationissimilartohumanPP2Cα,
where it binds phosphate [2]. In monomers C, Arg-13
adopts a new conformation, resembling Arg-17 of MspP in
complex with a sulphate ion [6]; the side chain is rotated
so that the guanidine group points away from the active
site and binds a serine residue (Ser155) of the monomer
A. A further indication for a role of this arginine residue
during catalysis comes for the crystal structure of human
PP2Cα, whose metals had been removed [2]. Reﬁnement
of the metal-free human PP2Cα structure revealed that it
was almost identical to the metal-bound enzyme with a
root mean square deviation of 0.4 ˚ Ab e t w e e na l la t o m s .
However,theguanidiniumgroupofArg-33ofhumanPP2Cα
shifts by 1 ˚ A due to dissociation of the phosphate ligand,
suggesting that this residue is ﬂexible and the conformation
of this residue depends on the presence of the phosphate ion
[2]. Although extensive structural studies suggest that this
conserved arginine residue plays an important role during
catalysis, it is still not well known from biochemical studies
how this residue aﬀects catalysis. Furthermore, this residue
is not universally conserved but may be replaced by lysine,
histidine, methionine, or alanine in some bacterial PP2C
homologues (see Supplementary ﬁle in [8]). So far, only
two variants (human PP2Cα R33A [12] and tPphA R13K
[13]) of this arginine residue were generated. In order to
further understand the function of this conserved residue
during catalysis, site-directed mutagenesis of the respective
Arg-13 of PP2C phosphatase tPphA into any other amino
acid residue was performed and the kinetic parameters of the
variants towards diﬀerent substrates were determined.
2.ExperimentalProcedures
2.1. Cloning, Overexpression, and Puriﬁcation of tPphA Vari-
ants. The random site-directed mutagenesis of Arg-13 was
carried out following the QuikChange XL (STRATAGENE)
protocol with two complementary primers containing three
random nucleotide at Arg-13 position (Table 1). The expres-
sion plasmid pET15b tPphA (pET15b hosting the gene
encoding wild type tPphA) [11] was used as the template for
the construction of the pphA gene variants. The mutagenesis
PCR was performed with Pfu turbo DNA polymerase using a
p r o g r a mo f1m i na t9 5 ◦C followed by 18 cycles at 95◦Cf o r
50s, 60◦C for 50s, 68◦C for 7min, and a ﬁnal extension at
68◦C for 7min. After PCR reaction, the restriction enzyme
Dpn I was directly added to the PCR reaction tube to
degrade the methylated template for 1h at 37◦C. After Dpn I
digestion, 3μL of the PCR mixture containing the ampliﬁed
pET15b tPphA variant plasmids was transformed into E. coli
XL-10 gold. The E. coli cells were grown overnight on LB
(Luria-Bertani) agar plates containing 100μg/mL ampicillin.
Then, 48 single colonies were picked from the LB plate
and streak cultivated on new LB plates overnight. Plasmids
were extracted from these 48 E.coli transformants by mini-
prep (peqGOLD Plasmid Miniprep Kit I). The generated
plasmids were transformed into E. coli BL21 (DE3), and
the transformants were grown on LB plates containing
100μg/mL ampicillin. The next day, from each clone of
transformed E. coli BL21 (DE3) cells, a 2mL liquid LB
medium containing 100μg/mL ampicillin was inoculated.Enzyme Research 3
When the O.D.600 of the liquid cultures reached a value of
1.0–1.5, 50μL aliquots were collected and Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to the remaining
liquid to a ﬁnal concentration of 0.5mM. After 3 hours
of IPTG induction, the cells were harvested and expression
of tPphA was analyzed by SDS-PAGE. All E. coli BL21
(DE3) transformants produced full-length tPphA variant
protein. The plasmids from all 48 transformants were
checked by DNA sequencing, using the T7 forward primer.
DNA sequencing revealed that the 48 sequences encoded
16 diﬀerent tPphA variants, whereas four possible variants
(R13A, R13C, R13E, and R13V) were not obtained by this
approach. The remaining variants were attempted to obtain
by new rounds of site-directed mutagenesis by using the
speciﬁc primers (Table 1). R13A and R13C were obtained
by this means: R13A was obtained with low yield (only one
clone in six trials), whereas the R13C variant was obtained
immediately. Remarkably,the R13E and R13V variants could
not be generated after two further site-directed mutagenesis
attempts. The sequences of the generated tPphA variant
plasmids are shown in Supplementary ﬁle 1 (available
online at doi: 10.1155/2012/272706) and the obtained codon
sequences at position 13 are summarized in Supplementary
ﬁle2.TheplasmidsweretransformedintoE.coliBL21(DE3)
for protein over expression and puriﬁcation as described
previously [11].
2.2. Assay of Phosphatase Activity with pNPP as Artiﬁcial
Substrate. The activities of the phosphatase variants towards
pNPP were assayed as described previously with modiﬁ-
cations [11]. Depending on the activity of the variants,
standard assays (250μL) contained 0.25μg–10μgt P p h A
variants in a buﬀer consisting of 50mM Tris-HCl, pH 8.3,
50mM NaCl, 1mM DTT, and 2mM MnCl2. Reactions
were started by the addition of 2mM pNPP at 30◦C, and
the increase in absorbance at 400nm was measured in an
ELx808 absorbance microplate reader (BioTek, Winooski,
USA) against a blank reaction without enzyme. For pNPP
catalytic constants, the pNPP concentration was varied from
0.1mM to 10mM. From the linear slope of each reaction,
the kinetic parameters Km and Vmax were calculated by
nonlinear hyperbolic ﬁtting according to the Michaelis-
Menten equation using the GraphPad Prism 4 program
(GraphPad Software Inc.).
2.3. Reactivity of tPphA and Its Variants towards Phosphopep-
tides. The activities of the phosphatase variants towards two
phosphopeptides (pT-peptide, RRA(pT)VA and pS-peptide,
RRA(pS)VA) were assayed as described previously [11]. In
a standard assay, 0.25μg–10μg tPphA variants were reacted
with100μMphosphopeptidesinareactionvolumeof100μL
containing 50mM Tris-HCl, pH 8.0, 50mM NaCl, 2mM
MnCl2, and 1mM DTT. Reactions were incubated at 30◦C
for 2–10 minutes, then stopped by the addition of 50μL
4.7M HCl. The released Pi was quantiﬁed colorimetrically
by the malachite-green assay [15, 16]. The absorbance of the
solution at 630nm was measured in an ELx808 absorbance
microplate reader (BioTek, Winooski, USA) against a blank
reaction, which was stopped at the start of the reaction by
adding 50μL 4.7M HCl. The activity of all enzymes towards
peptides was calculated with a phosphate standard.
3. Results and Discussion
3.1. Site-Directed Mutagenesis of tPphA. To study the role of
the Arg-13 residue in tPphA catalytic function, we attempted
to replace this amino acid by any of the other 19 amino
acids. For this purpose, random site-directed mutagenesis
is advantageous over speciﬁc site-directed mutagenesis,
since the former needs only one set of primers containing
randomizedbasepairsatthedesiredcodonposition,whereas
the latter one needs at least nineteen primers. Site-directed
mutagenesis PCR was performed with a primer containing
a randomized sequence at codon position 13 of the pphA
gene and using plasmid pET15b+tPphA [11]a st e m p l a t e .
After Dpn I digestion and transformation (see Section 2),
about 500 E. coli XL-10 gold colonies were grown on LB
plates. 48 clones were randomly selected and plasmids were
extractedfromthetransformants.Afterplasmidpuriﬁcation,
the 48 diﬀerent plasmids were transformed into E. coli BL21
(DE3)toinducerecombinantproteinsynthesis.Surprisingly,
all 48 transformants of E. coli BL21 (DE3) cells produced
full-length recombinant protein of 29kDa, meaning that
no plasmid contained a stop codon at position 13. DNA
sequence analysis of the mutated plasmids (Supplementary
ﬁle 1) showed that sixteen diﬀerent kinds of variants
were acquired from this random site-directed mutagenesis
approach. The codons at position 13 of these variants are
shown in Supplementary ﬁle 2. The overall distribution
probability of these gene codes follows the law of the gene
code with the amino acids encoded by six codons having
the highest possibility to be obtained (such as leucine). Four
variants, R13A, R13C, R13E, R13V, were not obtained from
this random site-directed mutagenesis. In order to obtain
the four variants, additional site-directed mutagenesis was
performed with four targeted pairs of primers (Table 1).
Strikingly, ﬁve attempts to generate R13A were unsuccessful.
Inthesixthattempt,onlyonesingleE.coliXL-10goldcolony
growing on the LB plate containing plasmid pET15b R13A
was obtained. Two variants, R13E and R13V, could not
be generated after two attempts. The reason for the very
low eﬃciency to generate the Arg-13 to Ala mutation and
the failure to obtain Glu and Val variants could indicate a
negative selection against these protein variants in E. coli.
3.2. Eﬀect of tPphA Mutations on Catalytic Activities: pNPP
HydrolysisActivity. All R13 variants of tPphA were produced
in E. coli BL21 (DE3) cells and puriﬁed on His-tag aﬃnity
columns. The SDS-PAGE of the 18 puriﬁed proteins used
for subsequent enzymatic assays is shown in Supplementary
ﬁle 3. The tPphA variants were ﬁrst tested with the artiﬁcial
chromogenic substrate pNPP. The variant R13K displayed
about 41% activity (Kcat/Km) as compared to wild-type
tPphA,whichwasmuchhigherthanallotherArg-13variants
(see Table 2 and Figure 1). In some bacterial PP2Cs, lysine
is found at this position (see Supplementary ﬁle in [8]).4 Enzyme Research
Table 2: Kinetic parameters of tPphA and Arg-13 variants towards pNPP. pNPP assays were carried out as described in Experimental
Procedures (Subsection 2.2). The pH of the reaction was 8.3. From the apparent reaction velocities of three independent repetitions, the
kinetic parameters were calculated by linear ﬁtting using the program GraphPad Prism 4. ± indicates standard error. The results were
obtained from single preparations of the wild-type (WT) and variant tPphA puriﬁcations.
Classiﬁcation of Arg-13 variants Variants Km [mM] (pNPP) Kcat [s−1] pNPP Kcat/Km [s−1M−1]
Arg-13 changed to residues with
electrically charged side chains
WT(R13R) 1.06 ±0.05 2.25 ±0.10 2122 ± 94
R13K 1.39 ±0.10 1.22 ±0.03 878 ±21
R13H 3.30 ±0.17 0.64 ±0.01 194 ± 3
R13D — — —
Arg-13 changed to residues with
polar uncharged side chains
R13S 3.85 ±0.32 1.06 ±0.04 275 ±10
R13T 5.37 ±1.00 0.94 ±0.08 175 ±15
R13N 4.73 ±0.53 0.81 ±0.04 171 ± 8
R13Q 4.06 ±0.21 0.50 ±0.01 123 ± 2
Arg-13 changed to residues with
hydrophobic side chains
R13A 5.11 ±0.23 1.56 ±0.03 305 ± 6
R13L — — —
R13I 4.58 ±0.54 0.75 ±0.04 164 ± 9
R13M 7.36 ±2.76 0.76 ±0.15 103 ±20
Arg-13 changed to residues with
aromatic side chains
R13F — — —
R13W — — —
R13Y 4.31 ±0.28 0.42 ±0.01 97 ±2
Arg-13 changed to residues with
special side chains
R13G 3.58 ±0.22 1.17 ±0.03 327 ± 8
R13C 4.27 ±0.39 0.79 ±0.01 185 ± 2
R13P 4.77 ±0.17 1.01 ±0.02 212 ± 4
—: not detectable.
The positively charged side chains of arginine and lysine
can both participate in electrostatic and hydrogen bond-
ing interactions with substrate, but with slightly diﬀerent
positions of the ligand. Thus, the replacement of arginine
by lysine could change the speciﬁcity of enzyme. Four
variants (R13L, R13F, R13W, and R13D) showed no activity
towards pNPP. Leucine, phenylalanine, and tryptophan have
long bulky hydrophobic side chains, whereas aspartate has
a negatively charged carboxyl side chain. The fact that
substitutionofthepositivelychargedargininebyanegatively
charged residue abolishes activity conﬁrms that this arginine
residue is involved in electrostatic substrate interactions. The
bulkyhydrophobicside chainsofleucine,phenylalanine,and
tryptophan may strongly aﬀect the structure of the catalytic
core of tPphA, resulting either in complete loss of function
or more speciﬁcally in inability to bind pNPP. In agreement
with this conclusion, the tyrosine and methionine variants
(R13Y and R13M), both of which are large and mainly
hydrophobic, showed the lowest activity of the remaining
variants, with the overall Kcat/Km reduced to a basal level
of about 5% of wild-type activity. The other ten Arg-13
variants showed about 7–15% residual activity and 3–5
times higher Km values than wild-type tPphA (Table 2).
The Kcat values of R13A and R13G variants were higher
than those that of the other mutant variants except R13K.
Alanine and glycine have the smallest side chains, so that
these substitutions may not inﬂuence the catalytic center of
tPphA. Thus, pN P Ps t i l lc o u l db ep r o c e s s e dq u i t ee ﬃciently
by these two variants. The Kcat value of the R13P variant
is only twofold lower that wild-type tPphA. Proline has a
cyclic structure and a ﬁxed ϕ angle. Arg-13 is located at a
β-turn connecting β1a n dβ2 sheets. Probably, proline at this
position does not aﬀect this β-turn. Together, these results
show that R13 is not absolutely essential for catalysis, but
that it is optimal for the reaction by positively aﬀecting Km
and Kcat for substrate binding and turnover. Negative charge
is not permitted and hydrophobic bulky side-chains are
inhibitory. As long as the space occupied by Arg-13 remains
free (Gly and Ala variants), an appreciable catalysis can take
place.
3.3. Reactivity of tPphA and Its Variants towards Phos-
phopeptides. To ﬁnd out whether the observed defects in
pNPP dephosphorylation are speciﬁc for this substrate or
reﬂect general impairment of catalysis, the variants were
also tested with two diﬀerent phosphopeptides (RRA(pT)VA
and RRA(pS)VA) as substrate. Strikingly, all variants could
dephosphorylate the two phosphopeptides, even when they
were inactive towards pNPP (R13W, R13L, R13F, R13D)
(Table 3, Figure 1). This shows that the phosphopeptides
recovered to a small but measurable extent the catalytic
activity in variants R13W, R13L, R13F, and R13D. The R13L
varianthadthelowestactivitytowardsphosphopeptides.The
long aliphatic side chain of leucine may interfere directly
with the catalytic centre of tPphA, impairing enzyme activity
regardless of the substrate. The fact that R13D recovered
someactivitytowardsphosphopeptideswasunexpected.The
carboxyl group of aspartate was expected to exclude theEnzyme Research 5
Table 3: The speciﬁc activity of tPphA and Arg-13 variants towards three phosphopeptides. Reactions were performed in the buﬀer as
described in Experimental Procedures (Subsection 2.3). Triplicate assays were used. ± indicates the standard error. The results were obtained
from single preparations of the wild-type (WT) and variant tPphA puriﬁcations.
Classiﬁcation of Arg-13 variants Variants Thr peptide nmol/min/μg Ser peptide nmol/min/μg
Arg-13 changed to residues with
electrically charged side chains
WT(R13R) 9.32 ±0.14 5.49 ±0.06
R13K 5.09 ±0.10 1.67 ±0.01
R13H 1.13 ±0.08 0.68 ±0.04
R13D 1.12 ±0.03 0.59 ±0.01
Arg-13 changed to residues with polar
uncharged side chains
R13S 1.47 ±0.02 1.07 ±0.02
R13T 1.28 ±0.02 1.13 ±0.02
R13N 1.13 ±0.06 0.78 ±0.03
R13Q 0.91 ±0.05 0.65 ±0.03
Arg-13 changed to residues with
hydrophobic side chains
R13A 1.40 ±0.02 0.81 ±0.01
R13L 0.26 ±0.02 0.05 ±0.01
R13I 1.67 ±0.01 0.90 ±0.01
R13M 1.55 ±0.07 0.84 ±0.01
Arg-13 changed to residues with aromatic
side chains
R13F 1.07 ±0.04 0.47 ±0.01
R13W 0.84 ±0.03 0.65 ±0.01
R13Y 0.91 ±0.01 0.89 ±0.02
Arg-13 changed to residues with special
side chains
R13G 0.74 ±0.04 1.04 ±0.02
R13C 1.21 ±0.03 0.98 ±0.03



















































































Figure 1: Relative activities of tPphA and Arg-13 variants, as indicated, towards diﬀerent substrates. The activities of wild-type tPphA
towards three substrates were set as 100% and the activities of the tPphA variants towards these substrates were adjusted accordingly. pNPP
indicates the value for Kcat/Km from the pNPP assay (Table 2). pT-peptide indicates the relative activity with RRA(pT)VA as substrate, pS-
peptide indicates the activity with RRA(pS)VA peptide as substrate (from Table 3).
substrate phosphate from the catalytic site. The gain of
activity using phosphopeptides compared to pNPP as sub-
strate might be achieved by a substrate-induced movement
of the aspartate side-chain. All together, the recovery of some
residual activity by using phosphopeptides as compared to
pNPP in various variants indicates that the ﬁve residues
neigbouring the phosphorylated residues (pT and pS) help
anchoring the phosphothreonyl- or phosphoseryl-residues
to the catalytic center. After anchoring, the phosphopeptides
may aﬀect the conformation of the catalytic centers of
tPphA variants in a way that productive enzyme-substrate
complexes are formed and the variants can dephosphorylate
these two peptides. This assumption agrees with previous
ﬁndings, where we showed that the free phosphorylated
amino acid phospho-serine and the tripeptide (G(pS)E)
cannotbedephosphorylatedbytPphA,whereasthehexapep-
tides can be dephosphorylated [11]. This indicates that
neighbouring interactions of the phosphorylated residue are
required for catalysis, either for proper binding or turnover
of the substrate.6 Enzyme Research
3.4. The Function of Arg-13 Residue of tPphA. In the crystal
structures of various PP2C homologues, the long
guanidinium side chain of the conserved arginine was
hydrogen bonded with phosphate ions or analogs in
diﬀerent conformations, suggesting that the arginyl-side
chain anchors the substrate phosphate at various stages
of catalysis. Whether this interaction is necessary for
catalysis was not clearly resolved. In this study, the kinetic
parameters of tPphA Arg-13 variants towards pNPP are
consistent with the suggestion of substrate binding, since
all the variants showed higher Km values than wild-type
tPphA. Furthermore, the decrease in Kcat value indicates
a role in substrate turn-over. Enzymatic characterization
of human PP2Cα reactivity towards pNPP indicated that
the phosphate release from this enzyme is the rate-limiting
step of catalysis [17]. The diﬀerent conformations of the
arginyl-side chain observed in PP2C crystal structures
indicate that this arginine residue could guide the phosphate
group through the catalytic cycle. The guanidinium side
chain of this arginine residue together with the metal center
could further play a role in stabilizing the transition state
of the substrate phosphate. In the absence of the conserved
arginine residue, the metal ions in the catalytic center of
PP2C can still stabilize the transition state of the phosphate
and break the covalent bond between phosphate and
the leaving group, but with decreased catalytic eﬃciency.
Following hydrolysis, the arginyl-side chain could drag the
phosphate ion from the catalytic center by its guanidium
side chain followed by release of the phosphate ion. This
suggestion agrees with the observed properties of the R13
variants: replacement of the arginyl-side chain by lysine has
only a modest eﬀect on both Kcat and Km, indicating that the
shorter lysine side chain can partially replace the function
of the arginyl-side chain. However, when the arginyl-residue
is replaced by any neutral residue, the reaction is impaired
more strongly, with both Km and Kcat being aﬀected. In
these variants, the substrate phosphate is not assisted by the
arginyl-side chain during catalysis; therefore, it binds weaker
and is released more slowly from the catalytic centre. The
diﬀerence between pNPP hydrolysis and phospho-peptide
dephosphorylation reﬂects the role of the neighbouring
amino acids for substrate binding. The failure of the R13W,
R13F, and R13L variants to dephosphorylate pNPP is,
therefore, more likely due to poor binding of pNPP than
to impaired turn-over. Those rare PP2C homologues, in
which this conserved arginine residue is substituted by other
residues,areexpectedtodisplaydiminishedcatalyticactivity.
The activity of the PP2C homologues can thus be adapted
in diﬀerent organisms and signal transduction pathways
towards fast or slow signal response by evolutionary changes
in the position of the conserved Arg residue.
The molecular mechanism of PP2Cs becomes more
and more clear, but there are still obvious open questions
about this type of protein phosphatase, such as the precise
mechanism of protein substrate recognition and how PP2Cs
are regulated. More biochemical studies of and new methods
are necessary to solve these issues.
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